Dr. Robyn Houlden is Professor and Chair of the Division of Endocrinology at Queen’s University, Kingston, Canada and a consultant in adult endocrinology at the Kingston Health Sciences Centre. She earned her MD at the University of Ottawa and completed internal medicine residency at Queen’s University. In 1988, she completed subspecialty training in Endocrinology, followed by a research fellowship at the University of Toronto. She joined Queen’s University as a faculty member in 1990 in the Department of Medicine.
Dr. Houlden has served as a diabetes advisor for the Canadian Optimal Medication Prescribing and Utilization Service of the Canadian Agency for Drugs and Technologies in Health, and the Ontario Ministry of Health. She is a member of the eConsult/eReferral Clinical Advisory Group for the Ontario Ministry of Health, and a provincial provider for eConsults in Endocrinology. She has been an investigator in a number of clinical trials of new therapies for diabetes, and has a research interest in innovative models of diabetes health care delivery. She has published over 150 peer reviewed papers. Dr. Houlden played a steering role in the 2003, 2008 and 2013 Canadian Diabetes Association Clinical Practice Guidelines for the management of diabetes and was Chair of the 2018 Diabetes Canada edition.
Throughout her career, she has been the recipient of several honours and awards. She has been recognized with 20 teaching awards including the Queen’s Department of Medicine Master Educator Award and the Canadian Society of Endocrinology and Metabolism Educator Award. In 2002, she was awarded the Charles H. Best Award by Diabetes Canada for her advocacy work in diabetes. In 2024, she was awarded the Canadian Society of Endocrinology and Metabolism Robert Volpe Distinguished Service Award.